Loss-of-function (LOF) variants in SLC22A5 (OCTN2) cause Carnitine Transporter Deficiency (CTD), a rare but potentially lethal inborn error of metabolism. This evidence concerns the gene SLC22A5 and systemic primary carnitine deficiency disease.